| Theresa P Little, MD | |
|
725 S Queen St Ste 4, Dover, DE 19904-3568 | |
| (302) 678-4488 | |
| (302) 678-4497 |
| Full Name | Theresa P Little |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 725 S Queen St Ste 4, Dover, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568471670 | NPI | - | NPPES |
| 0000418201 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | C1-0003798 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Internal Medicine Of Dover Pa | 5890861561 | 4 |
News Archive
Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT).
The states and D.C. are proposing demonstration projects to better coordinate and therefore improve care for an estimated 9 million people who fall into this category. States would receive a share of any resulting savings.
Science Week, a Pittcon sponsored annual 7-day event offering science education to students and teachers, will take place Oct. 20-26, 2018 at the David L. Lawrence Convention Center.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
For years now, America has been spending more money than we take in. The result is that we have too much debt on our nation's credit card — debt that will ultimately weaken our economy, lead to higher interest rates for all Americans, and leave us unable to invest in things like education, or protect vital programs like Medicare.
› Verified 4 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467546135 PECOS PAC ID: 1658364740 Enrollment ID: O20040405001600 |
News Archive
Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT).
The states and D.C. are proposing demonstration projects to better coordinate and therefore improve care for an estimated 9 million people who fall into this category. States would receive a share of any resulting savings.
Science Week, a Pittcon sponsored annual 7-day event offering science education to students and teachers, will take place Oct. 20-26, 2018 at the David L. Lawrence Convention Center.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
For years now, America has been spending more money than we take in. The result is that we have too much debt on our nation's credit card — debt that will ultimately weaken our economy, lead to higher interest rates for all Americans, and leave us unable to invest in things like education, or protect vital programs like Medicare.
› Verified 4 days ago
| Entity Name | Internal Medicine Of Dover Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184600942 PECOS PAC ID: 5890861561 Enrollment ID: O20080903000341 |
News Archive
Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT).
The states and D.C. are proposing demonstration projects to better coordinate and therefore improve care for an estimated 9 million people who fall into this category. States would receive a share of any resulting savings.
Science Week, a Pittcon sponsored annual 7-day event offering science education to students and teachers, will take place Oct. 20-26, 2018 at the David L. Lawrence Convention Center.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
For years now, America has been spending more money than we take in. The result is that we have too much debt on our nation's credit card — debt that will ultimately weaken our economy, lead to higher interest rates for all Americans, and leave us unable to invest in things like education, or protect vital programs like Medicare.
› Verified 4 days ago
| Entity Name | Apogee Medical Group Delaware Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326485285 PECOS PAC ID: 9638312572 Enrollment ID: O20130826000448 |
News Archive
Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT).
The states and D.C. are proposing demonstration projects to better coordinate and therefore improve care for an estimated 9 million people who fall into this category. States would receive a share of any resulting savings.
Science Week, a Pittcon sponsored annual 7-day event offering science education to students and teachers, will take place Oct. 20-26, 2018 at the David L. Lawrence Convention Center.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
For years now, America has been spending more money than we take in. The result is that we have too much debt on our nation's credit card — debt that will ultimately weaken our economy, lead to higher interest rates for all Americans, and leave us unable to invest in things like education, or protect vital programs like Medicare.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa P Little, MD 725 S Queen St, Dover, DE 19904-3568 Ph: (302) 678-4488 | Theresa P Little, MD 725 S Queen St Ste 4, Dover, DE 19904-3568 Ph: (302) 678-4488 |
News Archive
Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT).
The states and D.C. are proposing demonstration projects to better coordinate and therefore improve care for an estimated 9 million people who fall into this category. States would receive a share of any resulting savings.
Science Week, a Pittcon sponsored annual 7-day event offering science education to students and teachers, will take place Oct. 20-26, 2018 at the David L. Lawrence Convention Center.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
For years now, America has been spending more money than we take in. The result is that we have too much debt on our nation's credit card — debt that will ultimately weaken our economy, lead to higher interest rates for all Americans, and leave us unable to invest in things like education, or protect vital programs like Medicare.
› Verified 4 days ago
Aditya Brahmbhatt, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1074 South State Street, Mailcode: 3007, Dover, DE 19901 Phone: 302-725-3200 | |
Dr. Mushmoom Khan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1342 S Governors Ave, Dover, DE 19904 Phone: 302-734-2500 | |
Dr. Paul W Ford, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 870 S Governors Ave, Dover, DE 19904 Phone: 302-674-8088 Fax: 302-674-8213 | |
Jessica Magdeburger, Family Medicine Medicare: Medicare Enrolled Practice Location: 1342 S Governors Ave, Dover, DE 19904 Phone: 302-734-2500 Fax: 302-734-7758 | |
Dr. Henry Miller, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1074 S State St # 3007, Dover, DE 19901 Phone: 302-725-3200 | |
Dr. Joseph M Parise, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 S Queen St, Dover, DE 19904 Phone: 302-734-7834 Fax: 302-734-7847 | |
Lawrence Lewandowski, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Sunshine Health Professionals, 4601 S. Dupont Highway, Suite 2, Dover, DE 19901 Phone: 302-698-1100 Fax: 302-698-1187 |